Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl Peptidase 4”

Showing 20 of 0 results

Not applicableStudy completedNCT07240246
What this trial is testing

Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults

Who this might be right for
GLP-1Obesity &Amp; OverweightDietary Supplement
FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation 40
Post-approval studies (Phase 4)Study completedNCT01472432
What this trial is testing

DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes

Who this might be right for
Chronic Foot Ulcers
University of Campania Luigi Vanvitelli 106
Large-scale testing (Phase 3)Study completedNCT02043054
What this trial is testing

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Disease
University of Leicester 90
Large-scale testing (Phase 3)Study completedNCT02015299
What this trial is testing

Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
dr. DJ Mulder 45
Large-scale testing (Phase 3)Study completedNCT02314637
What this trial is testing

Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 240
Post-approval studies (Phase 4)Study completedNCT02122380
What this trial is testing

The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Vanderbilt University 23
Large-scale testing (Phase 3)Study completedNCT00411411
What this trial is testing

Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 49
Early research (Phase 1)Study completedNCT02749032
What this trial is testing

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Who this might be right for
Type 2 Diabetes
Michael A. Nauck 24
Not applicableUnknownNCT01588587
What this trial is testing

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Nagaoka Red Cross Hospital 500
Not applicableUnknownNCT01545024
What this trial is testing

Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Nagaoka Red Cross Hospital 60
Large-scale testing (Phase 3)Study completedNCT02273050
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,136
Large-scale testing (Phase 3)Study completedNCT00984867
What this trial is testing

Dapagliflozin DPPIV Inhibitor add-on Study

Who this might be right for
Type 2 Diabetes
AstraZeneca 833
Early research (Phase 1)Study completedNCT03310749
What this trial is testing

An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Stendhal Americas, S.A. 34
Large-scale testing (Phase 3)Ended earlyNCT02411084
What this trial is testing

Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD

Who this might be right for
Graft vs Host Disease
Adienne SA 36
Not applicableStudy completedNCT01677104
What this trial is testing

The Microvascular Function of GLP-1 and Its Analogues

Who this might be right for
Type 2 DiabetesObesity
Katarina Kos 63
Not applicableUnknownNCT05817097
What this trial is testing

Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database

Who this might be right for
Cerebral InfarctionInfarction, BrainDipeptidyl-Peptidase IV Inhibitors
Ajou University School of Medicine 22,119
Post-approval studies (Phase 4)Study completedNCT01449747
What this trial is testing

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
The Catholic University of Korea 24
Testing effectiveness (Phase 2)Study completedNCT00111670
What this trial is testing

DPP-IV Inhibitor in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 291
Large-scale testing (Phase 3)Study completedNCT02946541
What this trial is testing

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Who this might be right for
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd. 160
Not applicableStudy completedNCT02130687
What this trial is testing

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Who this might be right for
Type 2 Diabetes MellitusHypertension
Vanderbilt University 106
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation